Search

Lyn M Dyster

from Lewiston, NY
Age ~66
Get Report
Also known as:
Lyn M Yster, Lyn M Celenza, Lin M Dyster, Lyn R
Phone and address:
5061 Forest Rd, Stella Niagara, NY 14092
(716) 285-0257
Related to:
Caitlyn E Dyster, 25Tiana L Strzelczyk, 53Sally A Fernandez, 69John D DysterRebecca A Dyster, 68Michael L Celenza, 65Pamela Celenza, 60John G Dyster, 67Louis J FernandezMary Ann Celenza, 88Florist Fernandez Celenza
Connected to:
Melvin C Dyster, 33Dianne M Dysthe, 51Scott R Dyszelski, 59Jeremy E Dytrich, 44David P Dytrt, 60Thomas J Dytrych, 66William J Dytrych, 56Linda L Dyvig, 71Amy K Dyvik, 50Alon Dz, 49

Lyn Dyster Phones & Addresses

  • 5061 Forest Rd, Lewiston, NY 14092 (716) 285-0257 (716) 868-5922
  • Niagara Falls, NY
  • Buffalo, NY
  • Amherst, NY
  • 5061 Forest Rd, Lewiston, NY 14092

Resumes

Resumes

Lyn Dyster Photo 1

Co-Founder, Senior Vice President Operations

View page
Location:
5061 Forest Rd, Lewiston, NY 14092
Industry:
Biotechnology
Work:
Kinex Pharmaceuticals
Co-Founder, Senior Vice President Operations
Education:
University at Buffalo 1990
Doctorates, Doctor of Philosophy State University of New York College at Buffalo 1985 - 1990
Doctorates, Doctor of Philosophy, Biochemistry Niagara Catholic High School
Washington & Jefferson College
Bachelors, Bachelor of Arts, Biology
Skills:
Fda
Pharmaceutical Industry
Biotechnology
Technology Transfer
Lifesciences
Oncology
Gmp
Lyn Dyster Photo 2

Consultant

View page
Location:
Lewiston, NY
Work:

Consultant

Business Records

Name / Title
Company / Classification
Phones & Addresses
Lyn Dyster
Vice President Of Operations
Kinex Pharmaceutical
701 Ellicott St, Buffalo, NY 14203
Lyn M. Dyster
Vice-President
CH3 Biosystems, LLC
Biomedical Sciences · Services-Misc
1416 Sweet Home Rd, Buffalo, NY 14228
(716) 688-5222
Lyn M. Dyster
Buffalo Convention & Visitor Bureau
Travel Agency Business Association
617 Main St, Buffalo, NY 14203
403 Main St, Buffalo, NY 14203
(716) 852-2356
Lyn Dyster
BIOLYNE, INC
1576 Sweet Home Rd, Buffalo, NY 14228

Publications

Us Patents

Potentiated Disinfectant Cleaning Solutions And Methods Of Use

View page
US Patent:
6530384, Mar 11, 2003
Filed:
Jul 30, 2001
Appl. No.:
09/918382
Inventors:
Stephen J. Meyers - Williamsville NY
Lyn M. Dyster - Lewiston NY
Assignee:
Albert E. Nemmer - Clarence NY
International Classification:
B08B 304
US Classification:
134 252, 134 254, 134 42, 510199, 510319, 510384, 510391, 510423, 510433, 510504, 510240
Abstract:
Potentiated compositions and methods for disinfection of porous surfaces, such as ceiling tiles contaminated with bacteria and fungi permits renewal without requiring replacement tiles. The compositions, preferably water clear aqueous solutions, comprise synergistic combination of quaternary ammonium compound, a surfactant, and a hydrogen peroxide solution at very low concentrations than otherwise required if used alone. The active components are present in minimal proportional ranges sufficient to achieve a virtual 100 percent kill of bacteria and fungi present on surfaces.

Detection And Treatment Of Breast Disease

View page
US Patent:
6723518, Apr 20, 2004
Filed:
Apr 13, 2001
Appl. No.:
09/834795
Inventors:
Lawrence D. Papsidero - Orchard Park NY
Lyn M. Dyster - Lewiston NY
Jana M. Frustaci - Williamsville NY
Assignee:
Codon Diagnostics, LLC - Amherst NY
International Classification:
G01N 3353
US Classification:
435 71, 435 72, 435 721, 435 723, 435 724, 435 792, 435 791, 436501, 436503, 436 63, 436 64, 4241301
Abstract:
An isolated chemokine is disclosed. The isolated chemokine is expressed preferentially in breast tissue or can be detected in breast milk. It includes from about 100 to about 132 amino acids, has a deduced molecular weight of from about 10 to about 16 kDa, and has a deduced isoionic point of from about pH 10. 1 to about pH 10. 7. Antibodies and binding portions thereof recognizing the subject chemokine and peptides which include the antigenic portions of the subject chemokines are described. DNA molecules which encode the subject chemokines as well as nucleic acid molecules which, under stringent conditions, hybridize to nucleic acid molecules encoding the subject chemokines or to a complement thereof are also disclosed. The chemokines, peptides, antibodies and binding portions thereof, and nucleic acid molecules can be used to detect and treat breast disease, such as inflammations, infections, mastitis, benign cystitis, benign hyperplasias, cancer and other malignancies as well as other pathological states of the mammary gland.

Detection And Treatment Of Breast Disease

View page
US Patent:
20030026777, Feb 6, 2003
Filed:
Apr 13, 2001
Appl. No.:
09/834794
Inventors:
Lawrence Papsidero - Orchard Park NY, US
Lyn Dyster - Lewiston NY, US
Jana Frustaci - Williamsville NY, US
Assignee:
Codon Diagnostics, LLC
International Classification:
A61K039/395
C12N005/06
US Classification:
424/085100, 435/331000, 424/178100
Abstract:
An isolated chemokine is disclosed. The isolated chemokine is expressed preferentially in breast tissue or can be detected in breast milk. It includes from about 100 to about 132 amino acids, has a deduced molecular weight of from about 10 to about 16 kDa, and has a deduced isoionic point of from about pH 10.1 to about pH 10.7. Antibodies and binding portions thereof recognizing the subject chemokine and peptides which include the antigenic portions of the subject chemokines are described. DNA molecules which encode the subject chemokines as well as nucleic acid molecules which, under stringent conditions, hybridize to nucleic acid molecules encoding the subject chemokines or to a complement thereof are also disclosed. The chemokines, peptides, antibodies and binding portions thereof, and nucleic acid molecules can be used to detect and treat breast disease, such as inflammations, infections, mastitis, benign cystitis, benign hyperplasias, cancer and other malignancies as well as other pathological states of the mammary gland.

Detection And Treatment Of Breast Disease

View page
US Patent:
20050013796, Jan 20, 2005
Filed:
May 17, 2004
Appl. No.:
10/847824
Inventors:
Lawrence Papsidero - Orchard Park NY, US
Lyn Dyster - Lewiston NY, US
Jana Frustaci - Williamsville NY, US
Assignee:
Codon Diagnostics, LLC - Amherst NY
International Classification:
A61K038/19
US Classification:
424085100
Abstract:
An isolated chemokine is disclosed. The isolated chemokine is expressed preferentially in breast tissue or can be detected in breast milk. It includes from about 100 to about 132 amino acids, has a deduced molecular weight of from about 10 to about 16 kDa, and has a deduced isoionic point of from about pH 10.1 to about pH 10.7. Antibodies and binding portions thereof recognizing the subject chemokine and peptides which include the antigenic portions of the subject chemokines are described. DNA molecules which encode the subject chemokines as well as nucleic acid molecules which, under stringent conditions, hybridize to nucleic acid molecules encoding the subject chemokines or to a complement thereof are also disclosed. The chemokines, peptides, antibodies and binding portions thereof, and nucleic acid molecules can be used to detect and treat breast disease, such as inflammations, infections, mastitis, benign cystitis, benign hyperplasias, cancer and other malignancies as well as other pathological states of the mammary gland.

Detection And Treatment Of Breast Disease

View page
US Patent:
6306653, Oct 23, 2001
Filed:
Sep 3, 1998
Appl. No.:
9/146580
Inventors:
Lawrence D. Papsidero - Orchard Park NY
Lyn M. Dyster - Lewiston NY
Jana M. Frustaci - Williamsville NY
Assignee:
Codon Diagnostics, LLC - Amherst NY
International Classification:
C12N 512
A61K 3810
A61K 3804
C07K 1618
C07K 708
US Classification:
435331
Abstract:
An isolated chemokine is disclosed. The isolated chemokine is expressed preferentially in breast tissue or can be detected in breast milk. It includes from about 100 to about 132 amino acids, has a deduced molecular weight of from about 10 to about 16 kDa, and has a deduced isoionic point of from about pH 10. 1 to about pH 10. 7. Antibodies and binding portions thereof recognizing the subject chemokine and peptides which include the antigenic portions of the subject chemokines are described. DNA molecules which encode the subject chemokines as well as nucleic acid molecules which, under stringent conditions, hybridize to nucleic acid molecules encoding the subject chemokines or to a complement thereof are also disclosed. The chemokines, peptides, antibodies and binding portions thereof, and nucleic acid molecules can be used to detect and treat breast disease, such as inflammations, infections, mastitis, benign cystitis, benign hyperplasias, cancer and other malignancies as well as other pathological states of the mammary gland.
Control profile
Lyn M Dyster from Lewiston, NY, age ~66 Get Report